Navigation Links
Xencor Reports Second Quarter 2014 Financial Results
Date:7/31/2014

me period of 2013. For the six months ended June 30, 2014, net loss was $8.8 million, or $(0.28) on a fully diluted per share basis, compared to a net loss of $54.7 million, or $(4.35) on a fully diluted per basis for the same period in 2013. The lower loss on a per share basis in the three and six month periods ended June 30, 2014 compared to the same periods in 2013 are primarily due to a non-cash expense of $48.6 million related to the loss on the settlement of convertible notes that is reflected in the 2013 losses and the additional shares reflected in the 2014 per share calculations as a result of the Company's IPO in December 2013.

Cash balance totaled $66.2 million as of June 30, 2014, compared to $78.0 million on December 31, 2013.

Financial GuidanceBased on current operating plans, Xencor expects to have sufficient cash to fund research and development programs and operations through 2016, and maintains the 2014 year-end cash and cash equivalents estimate of approximately $54.0 million.

Conference Call and WebcastXencor will host a conference call today at 4:30 p.m. EDT to discuss these second quarter 2014 financial results and provide a corporate update.

The live call may be accessed by dialing (877) 359-9508 for domestic callers or (224) 357-2393 for international callers, and providing the conference ID number 74824866. A live webcast of the conference call will be available online from the investor relations section of the Company's website at www.xencor.com. The webcast will be archived on the company website for 30 days.

About Xencor, Inc.  
Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Currently, seven candidates are in clinical development internally and with partners that have been engineered with Xencor's
'/>"/>

SOURCE Xencor Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Xencor to Host Second Quarter 2014 Financial Results Webcast and Conference Call
2. Xencor Appoints Kurt Gustafson to Board of Directors; Promotes John Desjarlais to Chief Scientific Officer
3. Xencor, Inc. Announces Closing of Initial Public Offering
4. Pharmacyclics Reports Second Quarter 2014 Results
5. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
6. Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015
7. HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013
8. Endo Reports Second Quarter Financial Results
9. Columbia Laboratories Reports Second Quarter 2014 Financial Results
10. Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results
11. Hospira Reports Second-Quarter 2014 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 15, 2014  Mariel Therapeutics, Inc., a clinical stage ... application in Osteoarthritis (OA) and Chronic Kidney Disease (CKD), ... newly formed scientific advisory board. The newly appointed SAB ... to the company as it continues to develop therapies ... to have such leading experts in the area of ...
(Date:9/15/2014)... Chek Diagnostics, the U.S.-based manufacturer of both ... diagnostic products, has again been named to the ... in America. The Inc. 5000 ranking is ... Diagnostics earned its place on the list by growing ... For Chek Diagnostics, who appears on the ...
(Date:9/15/2014)... Research and Markets has announced the addition ... Analytics, Delivery Modes & by Whole Slide Image Storage ... to their offering. This report broadly ... and applications. Scanners accounted for the largest share of ... analytics market is expected to grow at the highest ...
Breaking Medicine Technology:Mariel Therapeutics Appoints World Leading Experts to Inaugural Scientific Advisory Board 2Mariel Therapeutics Appoints World Leading Experts to Inaugural Scientific Advisory Board 3Mariel Therapeutics Appoints World Leading Experts to Inaugural Scientific Advisory Board 4Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 3Global Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Forecasts & Trends to 2018 2Global Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Forecasts & Trends to 2018 3
... YORK, April 28, 2011 Reportlinker.com announces ... available in its catalogue: ... System and Drug Regulatory Overview: Cost-containment and ... http://www.reportlinker.com/p0487111/Pharmaceutical-Key-Trends-2011---Healthcare-System-and-Drug-Regulatory-Overview-Cost-containment-and-regulatory-pressures-intensify.html Introduction ...
... NEW YORK, April 28, 2011 Reportlinker.com announces that ... catalogue: Pharmaceutical Key Trends 2011 ... http://www.reportlinker.com/p0487118/Pharmaceutical-Key-Trends-2011---Brand-Erosion-Post-Patent-Expiry.html Introduction ... developed pharmaceutical markets, driven by increasing generic competition. However, ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 3Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 4Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 5Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 6Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry 3
(Date:9/16/2014)... Florida (PRWEB) September 16, 2014 ... of monthly specials this month, kicking off September ... day spa in Clearwater, FL chose to highlight ... for immediate activation upon contact with the skin. ... part of their best-selling lumafirm® anti-aging line. The ...
(Date:9/16/2014)... The Fertility Centers of New England is proud ... collaboration will give patients access to high-quality frozen donor ... Fertility Centers of New England. , Fairfax Egg Bank ... selection of frozen donor eggs. Access to frozen donor ... The Donor is already screened and her eggs ...
(Date:9/15/2014)... With the variety of drugs passing ... know the details on each one. However, it is ... falling into their teen’s hands. , Synthetic marijuana ... high school students. With varied, misleading and potentially unreliable ... can be difficult for parents to separate the truth ...
(Date:9/15/2014)... iFitDress.com, one of the most distinguished dress companies, ... evening dresses to its online store. In addition, the ... products. They are now provided at very low prices, up ... has confidence in the newly unveiled sapphire evening outfits. “I ... from all over the world. Up to now, over 200 ...
(Date:9/15/2014)... 2014 Aging skin inevitably wrinkles, thins and ... is loss of collagen production. By age 60, skin ... to this slow down. Collagen holds up skin structure. , ... be boosted. There are several ways to do this, but ... cells (non-embryonic). , "The cost is higher than other types ...
Breaking Medicine News(10 mins):Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 3Health News:FCNE Announces Partnership with Fairfax Egg Bank 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 3Health News:Beautiful Sapphire Evening Dresses Provided By iFitDress.com 2Health News:A Superior Way to Make Skin Younger and Assure Continual Collagen Production, from Sublime Beauty® 2
... A Pole who spent 19 years in a coma has woken up ... are no longer in power, a television station announced Friday. ... by a train in 1988, the private channel Polsat said. In an ... ,"She's the one who always took care of me. She ...
... man has contracted the deadly bird flu virus, becoming the country's ... Saturday. ,The 19-year-old man tested positive for the H5N1 strain ... Institute of Tropical Medicine in Hanoi, a doctor there told AFP. ... the victim had been admitted on May 19 and was now ...
... one source of counterfeit medicines, seized in the European Union ... ,About 31 percent of all fake medicines seized ... percent) and China (8). The three countries are responsible for ... report. ,The seized fake medicines included Viagra, Cialis ...
... found evidence that tropical cyclones and hurricanes play an ... transport heat and maintain the climate of North America ... University professor of earth and atmospheric sciences who led ... by MIT professor Kerry Emanuel that suggests there is ...
... Inc. announced it has successfully expanded the potential ... ELISA diagnostic research test, FAS-Detect(TM) ELISA for ... ,The current diagnostic technique for this disease is ... use presently, FASgen anticipates the opportunity for use ...
... a third child, but the actor is recoiling from making ... not come out in the open to declare that his ... who interviewed the actor, is of the view that if ... forward, awareness about autism would get a major boost. ...
Cached Medicine News:Health News:India Main Source of Counterfeit Medicines Seized in Europe 2Health News:India Main Source of Counterfeit Medicines Seized in Europe 3Health News:Tropical Cyclones Play Important Role in Climate-control 2Health News:FASgen Announces New Diagnostic Research Test for Steatohepatitis 2Health News:Travolta Maybe Reluctant to Publicaly Discuss About Sons Autism 2
... viscosity and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry ... 1000-5000 ... 0.8~1.5 Imprecision(%) ... 10 Dimensions: ...
... The Finnpipette Digital offers improved ergonomics ... rounded handle, modified grippy finger rest ... operator comfort and efficiency. Finnpipette Digitals ... power-boosted gearing mechanism (pat. pend.) and ...
Developed specifically for the 5000/5500 ultrasound consoles....
Super High Density, multi-frequency, phased array burr hole transducer. Excellent for taking biopsy samples and shunt placements....
Medicine Products: